Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-08-05

Clinical Trial Update: Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-02-41 [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial sponsored by Alcon Research evaluating an intraocular pressure-lowering therapy for open-angle glaucoma and ocular hypertension has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Alcon Research | Conditions: Open-Angle Glaucoma, Ocular Hypertension | Phase 3 | Status: COMPLETED